Lucy P. Marcus a Judge for BioPharm2020: UK-India Biotechnology Business Plan Challenge 2010
Lucy P. Marcus is a judge for BioPharm2020: UK-India Biotechnology Business Plan Challenge 2010.
BioPharm 2020: UK-India Biotechnology Business Challenge Grand Finale is being held on Friday 3rd September at the East Midlands Conference Centre, Nottingham, UK.
6 teams have been selected as finalists and they will pitch their business ideas, in confidence, to an eminent panel of judges.
The winning teams will be announced at an Awards Ceremony during the afternoon.
The Judging Panel
- Stefano Pessina (Panel Chair), Executive Chairman, Alliance Boots
- Ed Wass, Director, Catapult Venture Managers Ltd
- Nathu Puri, Chairman of Trustees of The Puri Foundation, The Three Râ€™s Education Trust, The Puri Foundation for Education in India
- Jonathan Dando, Managing Director, Dando Weiss and Colucci Ltd
- Lucy P. Marcus, Managing Director, Marcus Venture Consulting Ltd
Background to BioPharm 2020, a UK-India Science Bridge Collaboration
BioPharm 2020 is a major UK and India Science Bridge, established to create long-term collaborations in pharmaceutical research.
The University of Nottinghamâ€™s Schools of Pharmacy and Business, the Indian Institute of Technology, Kanpur and the Indian Institute of Management, Bangalore have joined forces to exploit the synergies between scientists and industries in India and the UK to create a step-change in collaborative innovation.
The Science Bridge is designed to bring together industrialists, academics and students to undertake research with the goals of delivering:
- clinical and commercial benefits from patent protected research, made possible by the synergistic research expertise across the Science Bridge
- world class human resources, with hands on experience of innovation and interfacing with Industry
- an assessment of the supply chain and outsourcing potential for long term business engagement between the two countries
- long-term collaborations exploiting the unique capabilities of each country.
Background to the BioPharm2020 UK-India Biotechnology Business Challenge
In February 2010, BioPharm 2020 launched a new business incubation competition to promote entrepreneurship in pharmaceutical sciences.
Scientists from UK and India (including scientists external to this Science Bridge) with promising Intellectual Property were encouraged to enter the BioPharm2020 Biotechnology Business Challenge and progress their business idea into a commercial opportunity.
On-line Master-classes from industry experts and entrepreneurs in different aspects of innovation were developed to assist scientists in developing their competition business plan submission.
Finalist teams were shortlisted at the end of May. Each team has been provided with mentors and specialist advisors to help them develop their full business plan and prepare for the final.
Two awards will be made in the afternoon of Friday 3rd September
The Best UK Entrant 2010 will receive:-
- Â£20,000 cash award for early start-up costs
- 12 months incubation facilities at BioCity Nottingham (lab space, office space or virtual tenancy)
- Up to 12 months business management support from BioCity Nottingham
- 12 months Medilink Membership
The Best India Entrant 2010 will receive:-
- Rs 5 lakhs cash award for early start-up costs
- 2 yearsâ€™ incubation facilities at SIDBI-Innovation and Incubation Centre (SIIC) of Indian Institute of Technology (providing room space, accommodation and support with IPR protection costs, lab testing and prototyping costs and more)